Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas
활용도 Analysis
논문 Analysis
연구자 Analysis
'
Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas' 의 참고문헌
WHO classification of tumours of the central nervous system
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Tumour-infiltrating T-cell subpopulations in glioblastomas
Tumour-infiltrating CD4(+)and CD8(+)lymphocytes as predictors of clinical outcome in glioma
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class
Tumor-infiltrating CD8+lymphocytes predict clinical outcome in breast cancer
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
Systematic analysis of overall survival and interactions between tumor mutations and drug treatment
Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab : a population-based study
Structure and interactions of the human programmed cell death 1 receptor
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
Relationship between expression of PD-L1and tumor angiogenesis, proliferation, and invasion in glioma
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
Pembrolizumab for the treatment of non-small-cell lung cancer
Pathology-based cancer registry 2001-2010
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients
PD-L1 expression and prognostic impact in glioblastoma
PD-L1 expression and CD8(+)T cell infiltration predict a favorable prognosis in advanced gastric cancer
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer
Immune checkpoints and innovative therapies in glioblastoma
Immune checkpoint blockade as a potential therapeutic target : surveying CNS malignancies
Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma : evidence of distinct immunological microenvironments that reflect tumor biology
Expression of the B7-related molecule B7-H1 by glioma cells : a potential mechanism of immune paralysis
Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas
Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors
Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1(PDL-1)and indoleamine 2, 3-dioxygenase(IDO)on tumour-specific T cell functions
Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): sensitivity analysis of trials in melanoma, lung and genitourinary cancers
Diagnostic and therapeutic biomarkers in glioblastoma : current status and future perspectives
Current state of Immunotherapy for treatment of glioblastoma
Combined nivolumab and ipilimumab or monotherapy in untreated melanoma
Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape
Clinical Neuropathology mini-review 6-2015 : PD-L1 : emerging biomarker in glioblastoma?
Cancer pathology registry:a 12 year registry 2000-2011
B7-homolog 1 expression by human glioma : a new mechanism of immune evasion
B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells
'
Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas'
의 유사주제(
